Global Cannabinoid Derived Pharmaceutical Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Cannabinoid Derived Pharmaceutical market size was estimated at USD 1035.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cannabinoid Derived Pharmaceutical market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cannabinoid Derived Pharmaceutical market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cannabinoid Derived Pharmaceutical market.
Global Cannabinoid Derived Pharmaceutical Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cara Therapeutics Inc
Arena Pharmaceuticals
Cannabics Pharmaceuticals Inc
Echo Pharmaceuticals
Gw Pharmaceuticals
Inmed Pharmaceuticals
Insys Therapeutics Inc
Larapharm
Mgc Pharmaceuticals Ltd
One World Cannabis
Orpheus Medica
Receptor Life Sciences
Respirerx Pharmaceuticals
Tetra Bio-Pharma
Cardiol Therapeutics
United Cannabis Corporation
Zynerba Pharmaceuticals
Market Segmentation (by Type)
Cannabinoid Receptor Type 1 (CB1)
Cannabinoid Receptor Type 2 (CB2)
Others
Market Segmentation (by Application)
Epilepsy
Migraine
Multiple Sclerosis
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cannabinoid Derived Pharmaceutical Market
Overview of the regional outlook of the Cannabinoid Derived Pharmaceutical Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabinoid Derived Pharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cannabinoid Derived Pharmaceutical, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cannabinoid Derived Pharmaceutical market size was estimated at USD 1035.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cannabinoid Derived Pharmaceutical market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cannabinoid Derived Pharmaceutical market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cannabinoid Derived Pharmaceutical market.
Global Cannabinoid Derived Pharmaceutical Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cara Therapeutics Inc
Arena Pharmaceuticals
Cannabics Pharmaceuticals Inc
Echo Pharmaceuticals
Gw Pharmaceuticals
Inmed Pharmaceuticals
Insys Therapeutics Inc
Larapharm
Mgc Pharmaceuticals Ltd
One World Cannabis
Orpheus Medica
Receptor Life Sciences
Respirerx Pharmaceuticals
Tetra Bio-Pharma
Cardiol Therapeutics
United Cannabis Corporation
Zynerba Pharmaceuticals
Market Segmentation (by Type)
Cannabinoid Receptor Type 1 (CB1)
Cannabinoid Receptor Type 2 (CB2)
Others
Market Segmentation (by Application)
Epilepsy
Migraine
Multiple Sclerosis
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cannabinoid Derived Pharmaceutical Market
Overview of the regional outlook of the Cannabinoid Derived Pharmaceutical Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabinoid Derived Pharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cannabinoid Derived Pharmaceutical, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cannabinoid Derived Pharmaceutical
1.2 Key Market Segments
1.2.1 Cannabinoid Derived Pharmaceutical Segment by Type
1.2.2 Cannabinoid Derived Pharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANNABINOID DERIVED PHARMACEUTICAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cannabinoid Derived Pharmaceutical Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cannabinoid Derived Pharmaceutical Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANNABINOID DERIVED PHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cannabinoid Derived Pharmaceutical Product Life Cycle
3.3 Global Cannabinoid Derived Pharmaceutical Sales by Manufacturers (2020-2025)
3.4 Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Manufacturers (2020-2025)
3.5 Cannabinoid Derived Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cannabinoid Derived Pharmaceutical Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cannabinoid Derived Pharmaceutical Market Competitive Situation and Trends
3.8.1 Cannabinoid Derived Pharmaceutical Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cannabinoid Derived Pharmaceutical Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANNABINOID DERIVED PHARMACEUTICAL INDUSTRY CHAIN ANALYSIS
4.1 Cannabinoid Derived Pharmaceutical Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANNABINOID DERIVED PHARMACEUTICAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cannabinoid Derived Pharmaceutical Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cannabinoid Derived Pharmaceutical Market
5.7 ESG Ratings of Leading Companies
6 CANNABINOID DERIVED PHARMACEUTICAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2020-2025)
6.3 Global Cannabinoid Derived Pharmaceutical Market Size by Type (2020-2025)
6.4 Global Cannabinoid Derived Pharmaceutical Price by Type (2020-2025)
7 CANNABINOID DERIVED PHARMACEUTICAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cannabinoid Derived Pharmaceutical Market Sales by Application (2020-2025)
7.3 Global Cannabinoid Derived Pharmaceutical Market Size (M USD) by Application (2020-2025)
7.4 Global Cannabinoid Derived Pharmaceutical Sales Growth Rate by Application (2020-2025)
8 CANNABINOID DERIVED PHARMACEUTICAL MARKET SALES BY REGION
8.1 Global Cannabinoid Derived Pharmaceutical Sales by Region
8.1.1 Global Cannabinoid Derived Pharmaceutical Sales by Region
8.1.2 Global Cannabinoid Derived Pharmaceutical Sales Market Share by Region
8.2 Global Cannabinoid Derived Pharmaceutical Market Size by Region
8.2.1 Global Cannabinoid Derived Pharmaceutical Market Size by Region
8.2.2 Global Cannabinoid Derived Pharmaceutical Market Size by Region
8.3 North America
8.3.1 North America Cannabinoid Derived Pharmaceutical Sales by Country
8.3.2 North America Cannabinoid Derived Pharmaceutical Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cannabinoid Derived Pharmaceutical Sales by Country
8.4.2 Europe Cannabinoid Derived Pharmaceutical Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cannabinoid Derived Pharmaceutical Sales by Region
8.5.2 Asia Pacific Cannabinoid Derived Pharmaceutical Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cannabinoid Derived Pharmaceutical Sales by Country
8.6.2 South America Cannabinoid Derived Pharmaceutical Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Region
8.7.2 Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANNABINOID DERIVED PHARMACEUTICAL MARKET PRODUCTION BY REGION
9.1 Global Production of Cannabinoid Derived Pharmaceutical by Region(2020-2025)
9.2 Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Region (2020-2025)
9.3 Global Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cannabinoid Derived Pharmaceutical Production
9.4.1 North America Cannabinoid Derived Pharmaceutical Production Growth Rate (2020-2025)
9.4.2 North America Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cannabinoid Derived Pharmaceutical Production
9.5.1 Europe Cannabinoid Derived Pharmaceutical Production Growth Rate (2020-2025)
9.5.2 Europe Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cannabinoid Derived Pharmaceutical Production (2020-2025)
9.6.1 Japan Cannabinoid Derived Pharmaceutical Production Growth Rate (2020-2025)
9.6.2 Japan Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cannabinoid Derived Pharmaceutical Production (2020-2025)
9.7.1 China Cannabinoid Derived Pharmaceutical Production Growth Rate (2020-2025)
9.7.2 China Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cara Therapeutics Inc
10.1.1 Cara Therapeutics Inc Basic Information
10.1.2 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Overview
10.1.3 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Market Performance
10.1.4 Cara Therapeutics Inc Business Overview
10.1.5 Cara Therapeutics Inc SWOT Analysis
10.1.6 Cara Therapeutics Inc Recent Developments
10.2 Arena Pharmaceuticals
10.2.1 Arena Pharmaceuticals Basic Information
10.2.2 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.2.3 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.2.4 Arena Pharmaceuticals Business Overview
10.2.5 Arena Pharmaceuticals SWOT Analysis
10.2.6 Arena Pharmaceuticals Recent Developments
10.3 Cannabics Pharmaceuticals Inc
10.3.1 Cannabics Pharmaceuticals Inc Basic Information
10.3.2 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product Overview
10.3.3 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product Market Performance
10.3.4 Cannabics Pharmaceuticals Inc Business Overview
10.3.5 Cannabics Pharmaceuticals Inc SWOT Analysis
10.3.6 Cannabics Pharmaceuticals Inc Recent Developments
10.4 Echo Pharmaceuticals
10.4.1 Echo Pharmaceuticals Basic Information
10.4.2 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.4.3 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.4.4 Echo Pharmaceuticals Business Overview
10.4.5 Echo Pharmaceuticals Recent Developments
10.5 Gw Pharmaceuticals
10.5.1 Gw Pharmaceuticals Basic Information
10.5.2 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.5.3 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.5.4 Gw Pharmaceuticals Business Overview
10.5.5 Gw Pharmaceuticals Recent Developments
10.6 Inmed Pharmaceuticals
10.6.1 Inmed Pharmaceuticals Basic Information
10.6.2 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.6.3 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.6.4 Inmed Pharmaceuticals Business Overview
10.6.5 Inmed Pharmaceuticals Recent Developments
10.7 Insys Therapeutics Inc
10.7.1 Insys Therapeutics Inc Basic Information
10.7.2 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Overview
10.7.3 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Market Performance
10.7.4 Insys Therapeutics Inc Business Overview
10.7.5 Insys Therapeutics Inc Recent Developments
10.8 Larapharm
10.8.1 Larapharm Basic Information
10.8.2 Larapharm Cannabinoid Derived Pharmaceutical Product Overview
10.8.3 Larapharm Cannabinoid Derived Pharmaceutical Product Market Performance
10.8.4 Larapharm Business Overview
10.8.5 Larapharm Recent Developments
10.9 Mgc Pharmaceuticals Ltd
10.9.1 Mgc Pharmaceuticals Ltd Basic Information
10.9.2 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product Overview
10.9.3 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product Market Performance
10.9.4 Mgc Pharmaceuticals Ltd Business Overview
10.9.5 Mgc Pharmaceuticals Ltd Recent Developments
10.10 One World Cannabis
10.10.1 One World Cannabis Basic Information
10.10.2 One World Cannabis Cannabinoid Derived Pharmaceutical Product Overview
10.10.3 One World Cannabis Cannabinoid Derived Pharmaceutical Product Market Performance
10.10.4 One World Cannabis Business Overview
10.10.5 One World Cannabis Recent Developments
10.11 Orpheus Medica
10.11.1 Orpheus Medica Basic Information
10.11.2 Orpheus Medica Cannabinoid Derived Pharmaceutical Product Overview
10.11.3 Orpheus Medica Cannabinoid Derived Pharmaceutical Product Market Performance
10.11.4 Orpheus Medica Business Overview
10.11.5 Orpheus Medica Recent Developments
10.12 Receptor Life Sciences
10.12.1 Receptor Life Sciences Basic Information
10.12.2 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product Overview
10.12.3 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product Market Performance
10.12.4 Receptor Life Sciences Business Overview
10.12.5 Receptor Life Sciences Recent Developments
10.13 Respirerx Pharmaceuticals
10.13.1 Respirerx Pharmaceuticals Basic Information
10.13.2 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.13.3 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.13.4 Respirerx Pharmaceuticals Business Overview
10.13.5 Respirerx Pharmaceuticals Recent Developments
10.14 Tetra Bio-Pharma
10.14.1 Tetra Bio-Pharma Basic Information
10.14.2 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product Overview
10.14.3 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product Market Performance
10.14.4 Tetra Bio-Pharma Business Overview
10.14.5 Tetra Bio-Pharma Recent Developments
10.15 Cardiol Therapeutics
10.15.1 Cardiol Therapeutics Basic Information
10.15.2 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product Overview
10.15.3 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product Market Performance
10.15.4 Cardiol Therapeutics Business Overview
10.15.5 Cardiol Therapeutics Recent Developments
10.16 United Cannabis Corporation
10.16.1 United Cannabis Corporation Basic Information
10.16.2 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product Overview
10.16.3 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product Market Performance
10.16.4 United Cannabis Corporation Business Overview
10.16.5 United Cannabis Corporation Recent Developments
10.17 Zynerba Pharmaceuticals
10.17.1 Zynerba Pharmaceuticals Basic Information
10.17.2 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.17.3 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.17.4 Zynerba Pharmaceuticals Business Overview
10.17.5 Zynerba Pharmaceuticals Recent Developments
11 CANNABINOID DERIVED PHARMACEUTICAL MARKET FORECAST BY REGION
11.1 Global Cannabinoid Derived Pharmaceutical Market Size Forecast
11.2 Global Cannabinoid Derived Pharmaceutical Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cannabinoid Derived Pharmaceutical Market Size Forecast by Country
11.2.3 Asia Pacific Cannabinoid Derived Pharmaceutical Market Size Forecast by Region
11.2.4 South America Cannabinoid Derived Pharmaceutical Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cannabinoid Derived Pharmaceutical by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cannabinoid Derived Pharmaceutical Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cannabinoid Derived Pharmaceutical by Type (2026-2035)
12.1.2 Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cannabinoid Derived Pharmaceutical by Type (2026-2035)
12.2 Global Cannabinoid Derived Pharmaceutical Market Forecast by Application (2026-2035)
12.2.1 Global Cannabinoid Derived Pharmaceutical Sales (K MT) Forecast by Application
12.2.2 Global Cannabinoid Derived Pharmaceutical Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cannabinoid Derived Pharmaceutical
1.2 Key Market Segments
1.2.1 Cannabinoid Derived Pharmaceutical Segment by Type
1.2.2 Cannabinoid Derived Pharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANNABINOID DERIVED PHARMACEUTICAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cannabinoid Derived Pharmaceutical Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cannabinoid Derived Pharmaceutical Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANNABINOID DERIVED PHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cannabinoid Derived Pharmaceutical Product Life Cycle
3.3 Global Cannabinoid Derived Pharmaceutical Sales by Manufacturers (2020-2025)
3.4 Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Manufacturers (2020-2025)
3.5 Cannabinoid Derived Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cannabinoid Derived Pharmaceutical Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cannabinoid Derived Pharmaceutical Market Competitive Situation and Trends
3.8.1 Cannabinoid Derived Pharmaceutical Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cannabinoid Derived Pharmaceutical Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANNABINOID DERIVED PHARMACEUTICAL INDUSTRY CHAIN ANALYSIS
4.1 Cannabinoid Derived Pharmaceutical Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANNABINOID DERIVED PHARMACEUTICAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cannabinoid Derived Pharmaceutical Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cannabinoid Derived Pharmaceutical Market
5.7 ESG Ratings of Leading Companies
6 CANNABINOID DERIVED PHARMACEUTICAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2020-2025)
6.3 Global Cannabinoid Derived Pharmaceutical Market Size by Type (2020-2025)
6.4 Global Cannabinoid Derived Pharmaceutical Price by Type (2020-2025)
7 CANNABINOID DERIVED PHARMACEUTICAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cannabinoid Derived Pharmaceutical Market Sales by Application (2020-2025)
7.3 Global Cannabinoid Derived Pharmaceutical Market Size (M USD) by Application (2020-2025)
7.4 Global Cannabinoid Derived Pharmaceutical Sales Growth Rate by Application (2020-2025)
8 CANNABINOID DERIVED PHARMACEUTICAL MARKET SALES BY REGION
8.1 Global Cannabinoid Derived Pharmaceutical Sales by Region
8.1.1 Global Cannabinoid Derived Pharmaceutical Sales by Region
8.1.2 Global Cannabinoid Derived Pharmaceutical Sales Market Share by Region
8.2 Global Cannabinoid Derived Pharmaceutical Market Size by Region
8.2.1 Global Cannabinoid Derived Pharmaceutical Market Size by Region
8.2.2 Global Cannabinoid Derived Pharmaceutical Market Size by Region
8.3 North America
8.3.1 North America Cannabinoid Derived Pharmaceutical Sales by Country
8.3.2 North America Cannabinoid Derived Pharmaceutical Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cannabinoid Derived Pharmaceutical Sales by Country
8.4.2 Europe Cannabinoid Derived Pharmaceutical Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cannabinoid Derived Pharmaceutical Sales by Region
8.5.2 Asia Pacific Cannabinoid Derived Pharmaceutical Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cannabinoid Derived Pharmaceutical Sales by Country
8.6.2 South America Cannabinoid Derived Pharmaceutical Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Region
8.7.2 Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANNABINOID DERIVED PHARMACEUTICAL MARKET PRODUCTION BY REGION
9.1 Global Production of Cannabinoid Derived Pharmaceutical by Region(2020-2025)
9.2 Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Region (2020-2025)
9.3 Global Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cannabinoid Derived Pharmaceutical Production
9.4.1 North America Cannabinoid Derived Pharmaceutical Production Growth Rate (2020-2025)
9.4.2 North America Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cannabinoid Derived Pharmaceutical Production
9.5.1 Europe Cannabinoid Derived Pharmaceutical Production Growth Rate (2020-2025)
9.5.2 Europe Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cannabinoid Derived Pharmaceutical Production (2020-2025)
9.6.1 Japan Cannabinoid Derived Pharmaceutical Production Growth Rate (2020-2025)
9.6.2 Japan Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cannabinoid Derived Pharmaceutical Production (2020-2025)
9.7.1 China Cannabinoid Derived Pharmaceutical Production Growth Rate (2020-2025)
9.7.2 China Cannabinoid Derived Pharmaceutical Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cara Therapeutics Inc
10.1.1 Cara Therapeutics Inc Basic Information
10.1.2 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Overview
10.1.3 Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Market Performance
10.1.4 Cara Therapeutics Inc Business Overview
10.1.5 Cara Therapeutics Inc SWOT Analysis
10.1.6 Cara Therapeutics Inc Recent Developments
10.2 Arena Pharmaceuticals
10.2.1 Arena Pharmaceuticals Basic Information
10.2.2 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.2.3 Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.2.4 Arena Pharmaceuticals Business Overview
10.2.5 Arena Pharmaceuticals SWOT Analysis
10.2.6 Arena Pharmaceuticals Recent Developments
10.3 Cannabics Pharmaceuticals Inc
10.3.1 Cannabics Pharmaceuticals Inc Basic Information
10.3.2 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product Overview
10.3.3 Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product Market Performance
10.3.4 Cannabics Pharmaceuticals Inc Business Overview
10.3.5 Cannabics Pharmaceuticals Inc SWOT Analysis
10.3.6 Cannabics Pharmaceuticals Inc Recent Developments
10.4 Echo Pharmaceuticals
10.4.1 Echo Pharmaceuticals Basic Information
10.4.2 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.4.3 Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.4.4 Echo Pharmaceuticals Business Overview
10.4.5 Echo Pharmaceuticals Recent Developments
10.5 Gw Pharmaceuticals
10.5.1 Gw Pharmaceuticals Basic Information
10.5.2 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.5.3 Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.5.4 Gw Pharmaceuticals Business Overview
10.5.5 Gw Pharmaceuticals Recent Developments
10.6 Inmed Pharmaceuticals
10.6.1 Inmed Pharmaceuticals Basic Information
10.6.2 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.6.3 Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.6.4 Inmed Pharmaceuticals Business Overview
10.6.5 Inmed Pharmaceuticals Recent Developments
10.7 Insys Therapeutics Inc
10.7.1 Insys Therapeutics Inc Basic Information
10.7.2 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Overview
10.7.3 Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Market Performance
10.7.4 Insys Therapeutics Inc Business Overview
10.7.5 Insys Therapeutics Inc Recent Developments
10.8 Larapharm
10.8.1 Larapharm Basic Information
10.8.2 Larapharm Cannabinoid Derived Pharmaceutical Product Overview
10.8.3 Larapharm Cannabinoid Derived Pharmaceutical Product Market Performance
10.8.4 Larapharm Business Overview
10.8.5 Larapharm Recent Developments
10.9 Mgc Pharmaceuticals Ltd
10.9.1 Mgc Pharmaceuticals Ltd Basic Information
10.9.2 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product Overview
10.9.3 Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product Market Performance
10.9.4 Mgc Pharmaceuticals Ltd Business Overview
10.9.5 Mgc Pharmaceuticals Ltd Recent Developments
10.10 One World Cannabis
10.10.1 One World Cannabis Basic Information
10.10.2 One World Cannabis Cannabinoid Derived Pharmaceutical Product Overview
10.10.3 One World Cannabis Cannabinoid Derived Pharmaceutical Product Market Performance
10.10.4 One World Cannabis Business Overview
10.10.5 One World Cannabis Recent Developments
10.11 Orpheus Medica
10.11.1 Orpheus Medica Basic Information
10.11.2 Orpheus Medica Cannabinoid Derived Pharmaceutical Product Overview
10.11.3 Orpheus Medica Cannabinoid Derived Pharmaceutical Product Market Performance
10.11.4 Orpheus Medica Business Overview
10.11.5 Orpheus Medica Recent Developments
10.12 Receptor Life Sciences
10.12.1 Receptor Life Sciences Basic Information
10.12.2 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product Overview
10.12.3 Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product Market Performance
10.12.4 Receptor Life Sciences Business Overview
10.12.5 Receptor Life Sciences Recent Developments
10.13 Respirerx Pharmaceuticals
10.13.1 Respirerx Pharmaceuticals Basic Information
10.13.2 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.13.3 Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.13.4 Respirerx Pharmaceuticals Business Overview
10.13.5 Respirerx Pharmaceuticals Recent Developments
10.14 Tetra Bio-Pharma
10.14.1 Tetra Bio-Pharma Basic Information
10.14.2 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product Overview
10.14.3 Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product Market Performance
10.14.4 Tetra Bio-Pharma Business Overview
10.14.5 Tetra Bio-Pharma Recent Developments
10.15 Cardiol Therapeutics
10.15.1 Cardiol Therapeutics Basic Information
10.15.2 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product Overview
10.15.3 Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product Market Performance
10.15.4 Cardiol Therapeutics Business Overview
10.15.5 Cardiol Therapeutics Recent Developments
10.16 United Cannabis Corporation
10.16.1 United Cannabis Corporation Basic Information
10.16.2 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product Overview
10.16.3 United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product Market Performance
10.16.4 United Cannabis Corporation Business Overview
10.16.5 United Cannabis Corporation Recent Developments
10.17 Zynerba Pharmaceuticals
10.17.1 Zynerba Pharmaceuticals Basic Information
10.17.2 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
10.17.3 Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Market Performance
10.17.4 Zynerba Pharmaceuticals Business Overview
10.17.5 Zynerba Pharmaceuticals Recent Developments
11 CANNABINOID DERIVED PHARMACEUTICAL MARKET FORECAST BY REGION
11.1 Global Cannabinoid Derived Pharmaceutical Market Size Forecast
11.2 Global Cannabinoid Derived Pharmaceutical Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cannabinoid Derived Pharmaceutical Market Size Forecast by Country
11.2.3 Asia Pacific Cannabinoid Derived Pharmaceutical Market Size Forecast by Region
11.2.4 South America Cannabinoid Derived Pharmaceutical Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cannabinoid Derived Pharmaceutical by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cannabinoid Derived Pharmaceutical Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cannabinoid Derived Pharmaceutical by Type (2026-2035)
12.1.2 Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cannabinoid Derived Pharmaceutical by Type (2026-2035)
12.2 Global Cannabinoid Derived Pharmaceutical Market Forecast by Application (2026-2035)
12.2.1 Global Cannabinoid Derived Pharmaceutical Sales (K MT) Forecast by Application
12.2.2 Global Cannabinoid Derived Pharmaceutical Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cannabinoid Derived Pharmaceutical Market Size by Type (M USD)
Table 4. Global Cannabinoid Derived Pharmaceutical Market Size by Application
Table 5. Cannabinoid Derived Pharmaceutical Market Size Comparison by Region (M USD)
Table 6. Global Cannabinoid Derived Pharmaceutical Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cannabinoid Derived Pharmaceutical Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cannabinoid Derived Pharmaceutical Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid Derived Pharmaceutical as of 2025)
Table 11. Global Market Cannabinoid Derived Pharmaceutical Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cannabinoid Derived Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cannabinoid Derived Pharmaceutical Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cannabinoid Derived Pharmaceutical Sales by Type (K MT)
Table 27. Global Cannabinoid Derived Pharmaceutical Market Size by Type (M USD)
Table 28. Global Cannabinoid Derived Pharmaceutical Sales (K MT) by Type (2020-2025)
Table 29. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2020-2025)
Table 30. Global Cannabinoid Derived Pharmaceutical Market Size (M USD) by Type (2020-2025)
Table 31. Global Cannabinoid Derived Pharmaceutical Market Share by Type (2020-2025)
Table 32. Global Cannabinoid Derived Pharmaceutical Price (USD/KG) by Type (2020-2025)
Table 33. Global Cannabinoid Derived Pharmaceutical Sales (K MT) by Application
Table 34. Global Cannabinoid Derived Pharmaceutical Market Size by Application
Table 35. Global Cannabinoid Derived Pharmaceutical Sales by Application (2020-2025) & (K MT)
Table 36. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2020-2025)
Table 37. Global Cannabinoid Derived Pharmaceutical Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cannabinoid Derived Pharmaceutical Market Share by Application (2020-2025)
Table 39. Global Cannabinoid Derived Pharmaceutical Sales Growth Rate by Application (2020-2025)
Table 40. Global Cannabinoid Derived Pharmaceutical Sales by Region (2020-2025) & (K MT)
Table 41. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Region (2020-2025)
Table 42. Global Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025)
Table 44. North America Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K MT)
Table 45. North America Cannabinoid Derived Pharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K MT)
Table 47. Europe Cannabinoid Derived Pharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cannabinoid Derived Pharmaceutical Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K MT)
Table 51. South America Cannabinoid Derived Pharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cannabinoid Derived Pharmaceutical Production (K MT) by Region(2020-2025)
Table 55. Global Cannabinoid Derived Pharmaceutical Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Region (2020-2025)
Table 57. Global Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cara Therapeutics Inc Basic Information
Table 63. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Overview
Table 64. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cara Therapeutics Inc Business Overview
Table 66. Cara Therapeutics Inc SWOT Analysis
Table 67. Cara Therapeutics Inc Recent Developments
Table 68. Arena Pharmaceuticals Basic Information
Table 69. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 70. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Arena Pharmaceuticals Business Overview
Table 72. Arena Pharmaceuticals SWOT Analysis
Table 73. Arena Pharmaceuticals Recent Developments
Table 74. Cannabics Pharmaceuticals Inc Basic Information
Table 75. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product Overview
Table 76. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Cannabics Pharmaceuticals Inc Business Overview
Table 78. Cannabics Pharmaceuticals Inc SWOT Analysis
Table 79. Cannabics Pharmaceuticals Inc Recent Developments
Table 80. Echo Pharmaceuticals Basic Information
Table 81. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 82. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Echo Pharmaceuticals Business Overview
Table 84. Echo Pharmaceuticals Recent Developments
Table 85. Gw Pharmaceuticals Basic Information
Table 86. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 87. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Gw Pharmaceuticals Business Overview
Table 89. Gw Pharmaceuticals Recent Developments
Table 90. Inmed Pharmaceuticals Basic Information
Table 91. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 92. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Inmed Pharmaceuticals Business Overview
Table 94. Inmed Pharmaceuticals Recent Developments
Table 95. Insys Therapeutics Inc Basic Information
Table 96. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Overview
Table 97. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Insys Therapeutics Inc Business Overview
Table 99. Insys Therapeutics Inc Recent Developments
Table 100. Larapharm Basic Information
Table 101. Larapharm Cannabinoid Derived Pharmaceutical Product Overview
Table 102. Larapharm Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Larapharm Business Overview
Table 104. Larapharm Recent Developments
Table 105. Mgc Pharmaceuticals Ltd Basic Information
Table 106. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product Overview
Table 107. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Mgc Pharmaceuticals Ltd Business Overview
Table 109. Mgc Pharmaceuticals Ltd Recent Developments
Table 110. One World Cannabis Basic Information
Table 111. One World Cannabis Cannabinoid Derived Pharmaceutical Product Overview
Table 112. One World Cannabis Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. One World Cannabis Business Overview
Table 114. One World Cannabis Recent Developments
Table 115. Orpheus Medica Basic Information
Table 116. Orpheus Medica Cannabinoid Derived Pharmaceutical Product Overview
Table 117. Orpheus Medica Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Orpheus Medica Business Overview
Table 119. Orpheus Medica Recent Developments
Table 120. Receptor Life Sciences Basic Information
Table 121. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product Overview
Table 122. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Receptor Life Sciences Business Overview
Table 124. Receptor Life Sciences Recent Developments
Table 125. Respirerx Pharmaceuticals Basic Information
Table 126. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 127. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Respirerx Pharmaceuticals Business Overview
Table 129. Respirerx Pharmaceuticals Recent Developments
Table 130. Tetra Bio-Pharma Basic Information
Table 131. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product Overview
Table 132. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Tetra Bio-Pharma Business Overview
Table 134. Tetra Bio-Pharma Recent Developments
Table 135. Cardiol Therapeutics Basic Information
Table 136. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product Overview
Table 137. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Cardiol Therapeutics Business Overview
Table 139. Cardiol Therapeutics Recent Developments
Table 140. United Cannabis Corporation Basic Information
Table 141. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product Overview
Table 142. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. United Cannabis Corporation Business Overview
Table 144. United Cannabis Corporation Recent Developments
Table 145. Zynerba Pharmaceuticals Basic Information
Table 146. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 147. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Zynerba Pharmaceuticals Business Overview
Table 149. Zynerba Pharmaceuticals Recent Developments
Table 150. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Cannabinoid Derived Pharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Cannabinoid Derived Pharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Cannabinoid Derived Pharmaceutical Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Cannabinoid Derived Pharmaceutical Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Cannabinoid Derived Pharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Cannabinoid Derived Pharmaceutical Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Cannabinoid Derived Pharmaceutical Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cannabinoid Derived Pharmaceutical Market Size by Type (M USD)
Table 4. Global Cannabinoid Derived Pharmaceutical Market Size by Application
Table 5. Cannabinoid Derived Pharmaceutical Market Size Comparison by Region (M USD)
Table 6. Global Cannabinoid Derived Pharmaceutical Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cannabinoid Derived Pharmaceutical Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cannabinoid Derived Pharmaceutical Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid Derived Pharmaceutical as of 2025)
Table 11. Global Market Cannabinoid Derived Pharmaceutical Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cannabinoid Derived Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cannabinoid Derived Pharmaceutical Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cannabinoid Derived Pharmaceutical Sales by Type (K MT)
Table 27. Global Cannabinoid Derived Pharmaceutical Market Size by Type (M USD)
Table 28. Global Cannabinoid Derived Pharmaceutical Sales (K MT) by Type (2020-2025)
Table 29. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2020-2025)
Table 30. Global Cannabinoid Derived Pharmaceutical Market Size (M USD) by Type (2020-2025)
Table 31. Global Cannabinoid Derived Pharmaceutical Market Share by Type (2020-2025)
Table 32. Global Cannabinoid Derived Pharmaceutical Price (USD/KG) by Type (2020-2025)
Table 33. Global Cannabinoid Derived Pharmaceutical Sales (K MT) by Application
Table 34. Global Cannabinoid Derived Pharmaceutical Market Size by Application
Table 35. Global Cannabinoid Derived Pharmaceutical Sales by Application (2020-2025) & (K MT)
Table 36. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2020-2025)
Table 37. Global Cannabinoid Derived Pharmaceutical Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cannabinoid Derived Pharmaceutical Market Share by Application (2020-2025)
Table 39. Global Cannabinoid Derived Pharmaceutical Sales Growth Rate by Application (2020-2025)
Table 40. Global Cannabinoid Derived Pharmaceutical Sales by Region (2020-2025) & (K MT)
Table 41. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Region (2020-2025)
Table 42. Global Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025)
Table 44. North America Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K MT)
Table 45. North America Cannabinoid Derived Pharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K MT)
Table 47. Europe Cannabinoid Derived Pharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cannabinoid Derived Pharmaceutical Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K MT)
Table 51. South America Cannabinoid Derived Pharmaceutical Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cannabinoid Derived Pharmaceutical Production (K MT) by Region(2020-2025)
Table 55. Global Cannabinoid Derived Pharmaceutical Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Region (2020-2025)
Table 57. Global Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Cannabinoid Derived Pharmaceutical Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cara Therapeutics Inc Basic Information
Table 63. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Overview
Table 64. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cara Therapeutics Inc Business Overview
Table 66. Cara Therapeutics Inc SWOT Analysis
Table 67. Cara Therapeutics Inc Recent Developments
Table 68. Arena Pharmaceuticals Basic Information
Table 69. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 70. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Arena Pharmaceuticals Business Overview
Table 72. Arena Pharmaceuticals SWOT Analysis
Table 73. Arena Pharmaceuticals Recent Developments
Table 74. Cannabics Pharmaceuticals Inc Basic Information
Table 75. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product Overview
Table 76. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Cannabics Pharmaceuticals Inc Business Overview
Table 78. Cannabics Pharmaceuticals Inc SWOT Analysis
Table 79. Cannabics Pharmaceuticals Inc Recent Developments
Table 80. Echo Pharmaceuticals Basic Information
Table 81. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 82. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Echo Pharmaceuticals Business Overview
Table 84. Echo Pharmaceuticals Recent Developments
Table 85. Gw Pharmaceuticals Basic Information
Table 86. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 87. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Gw Pharmaceuticals Business Overview
Table 89. Gw Pharmaceuticals Recent Developments
Table 90. Inmed Pharmaceuticals Basic Information
Table 91. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 92. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Inmed Pharmaceuticals Business Overview
Table 94. Inmed Pharmaceuticals Recent Developments
Table 95. Insys Therapeutics Inc Basic Information
Table 96. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Overview
Table 97. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Insys Therapeutics Inc Business Overview
Table 99. Insys Therapeutics Inc Recent Developments
Table 100. Larapharm Basic Information
Table 101. Larapharm Cannabinoid Derived Pharmaceutical Product Overview
Table 102. Larapharm Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Larapharm Business Overview
Table 104. Larapharm Recent Developments
Table 105. Mgc Pharmaceuticals Ltd Basic Information
Table 106. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product Overview
Table 107. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Mgc Pharmaceuticals Ltd Business Overview
Table 109. Mgc Pharmaceuticals Ltd Recent Developments
Table 110. One World Cannabis Basic Information
Table 111. One World Cannabis Cannabinoid Derived Pharmaceutical Product Overview
Table 112. One World Cannabis Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. One World Cannabis Business Overview
Table 114. One World Cannabis Recent Developments
Table 115. Orpheus Medica Basic Information
Table 116. Orpheus Medica Cannabinoid Derived Pharmaceutical Product Overview
Table 117. Orpheus Medica Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Orpheus Medica Business Overview
Table 119. Orpheus Medica Recent Developments
Table 120. Receptor Life Sciences Basic Information
Table 121. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product Overview
Table 122. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Receptor Life Sciences Business Overview
Table 124. Receptor Life Sciences Recent Developments
Table 125. Respirerx Pharmaceuticals Basic Information
Table 126. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 127. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Respirerx Pharmaceuticals Business Overview
Table 129. Respirerx Pharmaceuticals Recent Developments
Table 130. Tetra Bio-Pharma Basic Information
Table 131. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product Overview
Table 132. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Tetra Bio-Pharma Business Overview
Table 134. Tetra Bio-Pharma Recent Developments
Table 135. Cardiol Therapeutics Basic Information
Table 136. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product Overview
Table 137. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Cardiol Therapeutics Business Overview
Table 139. Cardiol Therapeutics Recent Developments
Table 140. United Cannabis Corporation Basic Information
Table 141. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product Overview
Table 142. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. United Cannabis Corporation Business Overview
Table 144. United Cannabis Corporation Recent Developments
Table 145. Zynerba Pharmaceuticals Basic Information
Table 146. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Overview
Table 147. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Zynerba Pharmaceuticals Business Overview
Table 149. Zynerba Pharmaceuticals Recent Developments
Table 150. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Cannabinoid Derived Pharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Cannabinoid Derived Pharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Cannabinoid Derived Pharmaceutical Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Cannabinoid Derived Pharmaceutical Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Cannabinoid Derived Pharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Cannabinoid Derived Pharmaceutical Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Cannabinoid Derived Pharmaceutical Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cannabinoid Derived Pharmaceutical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cannabinoid Derived Pharmaceutical Market Size (M USD), 2025-2035
Figure 5. Global Cannabinoid Derived Pharmaceutical Market Size (M USD) (2020-2035)
Figure 6. Global Cannabinoid Derived Pharmaceutical Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cannabinoid Derived Pharmaceutical Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cannabinoid Derived Pharmaceutical Product Life Cycle
Figure 13. Cannabinoid Derived Pharmaceutical Sales Share by Manufacturers in 2025
Figure 14. Global Cannabinoid Derived Pharmaceutical Revenue Share by Manufacturers in 2025
Figure 15. Cannabinoid Derived Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cannabinoid Derived Pharmaceutical Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cannabinoid Derived Pharmaceutical Revenue in 2025
Figure 18. Industry Chain Map of Cannabinoid Derived Pharmaceutical
Figure 19. Global Cannabinoid Derived Pharmaceutical Market PEST Analysis
Figure 20. Global Cannabinoid Derived Pharmaceutical Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cannabinoid Derived Pharmaceutical Market Share by Type
Figure 27. Sales Market Share of Cannabinoid Derived Pharmaceutical by Type (2020-2025)
Figure 28. Sales Market Share of Cannabinoid Derived Pharmaceutical by Type in 2025
Figure 29. Market Share of Cannabinoid Derived Pharmaceutical by Type (2020-2025)
Figure 30. Market Share of Cannabinoid Derived Pharmaceutical by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cannabinoid Derived Pharmaceutical Market Share by Application
Figure 33. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2020-2025)
Figure 34. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application in 2025
Figure 35. Global Cannabinoid Derived Pharmaceutical Market Share by Application (2020-2025)
Figure 36. Global Cannabinoid Derived Pharmaceutical Market Share by Application in 2025
Figure 37. Global Cannabinoid Derived Pharmaceutical Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Region (2020-2025)
Figure 39. Global Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025)
Figure 40. North America Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Cannabinoid Derived Pharmaceutical Sales Market Share by Country in 2024
Figure 43. North America Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cannabinoid Derived Pharmaceutical Market Size by Country in 2024
Figure 45. U.S. Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cannabinoid Derived Pharmaceutical Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Cannabinoid Derived Pharmaceutical Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cannabinoid Derived Pharmaceutical Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cannabinoid Derived Pharmaceutical Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Cannabinoid Derived Pharmaceutical Sales Market Share by Country in 2024
Figure 53. Europe Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cannabinoid Derived Pharmaceutical Market Size by Country in 2024
Figure 55. Germany Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cannabinoid Derived Pharmaceutical Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Cannabinoid Derived Pharmaceutical Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cannabinoid Derived Pharmaceutical Market Size by Region in 2024
Figure 68. China Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cannabinoid Derived Pharmaceutical Sales and Growth Rate (K MT)
Figure 79. South America Cannabinoid Derived Pharmaceutical Sales Market Share by Country in 2024
Figure 80. South America Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (M USD)
Figure 81. South America Cannabinoid Derived Pharmaceutical Market Size by Country in 2024
Figure 82. Brazil Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size by Region in 2024
Figure 92. Saudi Arabia Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cannabinoid Derived Pharmaceutical Production Market Share by Region (2020-2025)
Figure 103. North America Cannabinoid Derived Pharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Cannabinoid Derived Pharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Cannabinoid Derived Pharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 106. China Cannabinoid Derived Pharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cannabinoid Derived Pharmaceutical Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cannabinoid Derived Pharmaceutical Market Share Forecast by Type (2026-2035)
Figure 111. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Application (2026-2035)
Figure 112. Global Cannabinoid Derived Pharmaceutical Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Cannabinoid Derived Pharmaceutical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cannabinoid Derived Pharmaceutical Market Size (M USD), 2025-2035
Figure 5. Global Cannabinoid Derived Pharmaceutical Market Size (M USD) (2020-2035)
Figure 6. Global Cannabinoid Derived Pharmaceutical Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cannabinoid Derived Pharmaceutical Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cannabinoid Derived Pharmaceutical Product Life Cycle
Figure 13. Cannabinoid Derived Pharmaceutical Sales Share by Manufacturers in 2025
Figure 14. Global Cannabinoid Derived Pharmaceutical Revenue Share by Manufacturers in 2025
Figure 15. Cannabinoid Derived Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cannabinoid Derived Pharmaceutical Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cannabinoid Derived Pharmaceutical Revenue in 2025
Figure 18. Industry Chain Map of Cannabinoid Derived Pharmaceutical
Figure 19. Global Cannabinoid Derived Pharmaceutical Market PEST Analysis
Figure 20. Global Cannabinoid Derived Pharmaceutical Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cannabinoid Derived Pharmaceutical Market Share by Type
Figure 27. Sales Market Share of Cannabinoid Derived Pharmaceutical by Type (2020-2025)
Figure 28. Sales Market Share of Cannabinoid Derived Pharmaceutical by Type in 2025
Figure 29. Market Share of Cannabinoid Derived Pharmaceutical by Type (2020-2025)
Figure 30. Market Share of Cannabinoid Derived Pharmaceutical by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cannabinoid Derived Pharmaceutical Market Share by Application
Figure 33. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2020-2025)
Figure 34. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application in 2025
Figure 35. Global Cannabinoid Derived Pharmaceutical Market Share by Application (2020-2025)
Figure 36. Global Cannabinoid Derived Pharmaceutical Market Share by Application in 2025
Figure 37. Global Cannabinoid Derived Pharmaceutical Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Region (2020-2025)
Figure 39. Global Cannabinoid Derived Pharmaceutical Market Size by Region (2020-2025)
Figure 40. North America Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Cannabinoid Derived Pharmaceutical Sales Market Share by Country in 2024
Figure 43. North America Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cannabinoid Derived Pharmaceutical Market Size by Country in 2024
Figure 45. U.S. Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cannabinoid Derived Pharmaceutical Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Cannabinoid Derived Pharmaceutical Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cannabinoid Derived Pharmaceutical Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cannabinoid Derived Pharmaceutical Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Cannabinoid Derived Pharmaceutical Sales Market Share by Country in 2024
Figure 53. Europe Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cannabinoid Derived Pharmaceutical Market Size by Country in 2024
Figure 55. Germany Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cannabinoid Derived Pharmaceutical Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Cannabinoid Derived Pharmaceutical Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cannabinoid Derived Pharmaceutical Market Size by Region in 2024
Figure 68. China Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cannabinoid Derived Pharmaceutical Sales and Growth Rate (K MT)
Figure 79. South America Cannabinoid Derived Pharmaceutical Sales Market Share by Country in 2024
Figure 80. South America Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (M USD)
Figure 81. South America Cannabinoid Derived Pharmaceutical Market Size by Country in 2024
Figure 82. Brazil Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cannabinoid Derived Pharmaceutical Market Size by Region in 2024
Figure 92. Saudi Arabia Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cannabinoid Derived Pharmaceutical Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Cannabinoid Derived Pharmaceutical Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cannabinoid Derived Pharmaceutical Production Market Share by Region (2020-2025)
Figure 103. North America Cannabinoid Derived Pharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Cannabinoid Derived Pharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Cannabinoid Derived Pharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 106. China Cannabinoid Derived Pharmaceutical Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Cannabinoid Derived Pharmaceutical Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cannabinoid Derived Pharmaceutical Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cannabinoid Derived Pharmaceutical Market Share Forecast by Type (2026-2035)
Figure 111. Global Cannabinoid Derived Pharmaceutical Sales Forecast by Application (2026-2035)
Figure 112. Global Cannabinoid Derived Pharmaceutical Market Share Forecast by Application (2026-2035)
